4//SEC Filing
KADOCH CIGALL 4
Accession 0001562180-21-004934
CIK 0001822462other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:53 PM ET
Size
5.4 KB
Accession
0001562180-21-004934
Insider Transaction Report
Form 4
KADOCH CIGALL
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-07-13+12,530→ 12,530 totalExercise: $9.40From: 2022-07-13Exp: 2031-07-12→ Common Stock (12,530 underlying)
Footnotes (1)
- [F1]The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001828726
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 4:53 PM ET
- Size
- 5.4 KB